Comparative effectiveness of immunotherapy and chemotherapy in patients with metastatic colorectal cancer stratified by microsatellite instability status

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

725

Figures (1-1)

156

Tables (1-4)

153

Sum=1077

Publishing Process of This Article

Item

Count

Browse

Download

199

Sum=273

Apr 24, 2024 (publication date) through Jan 9, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Oncol. Apr 24, 2024; 15(4): 540-547
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.540

Table 3 Comparative analysis of survival rates

Survival rate	Microsatellite stable		Microsatellite instability-high
Survival rate	Immunotherapy	Chemotherapy	Immunotherapy	Chemotherapy
1 yr (%)	71.96 (61.14-80.25)	76.78 (75.83-77.70)	76.55 (68.64-82.72)	69.91 (66.65-72.91)
3 yr (%)	48.06 (35.30-58.70)	40.38 (39.01-41.74)	50.96 (39.83-61.04)	44.35 (40.38-48.24)

Citation: Niu CG, Zhang J, Rao AV, Joshi U, Okolo P. Comparative effectiveness of immunotherapy and chemotherapy in patients with metastatic colorectal cancer stratified by microsatellite instability status. World J Clin Oncol 2024; 15(4): 540-547
URL: https://www.wjgnet.com/2218-4333/full/v15/i4/540.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i4.540